Opportunity Information: Apply for W81XWH 14 TSCRP EHDA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Tuberous Sclerosis Complex Exploration Hypothesis Development Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on May 28, 2014 and posted on May 27, 2014.
  • Applicants must submit their applications by Jul 24, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $1,120,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 7 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 14 TSCRP EHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DoD Tuberous Sclerosis Complex Research Program (TSCRP) Exploration Hypothesis Development Award (EHDA) is a U.S. Army Medical Research Acquisition Activity (USAMRAA) funding opportunity designed to kick-start bold, early-stage ideas in tuberous sclerosis complex (TSC) research. It specifically targets projects that are high risk but potentially high reward, with the expectation that funded work will open new directions in the field and generate a foundation for future, more extensive studies. This mechanism has been offered since FY07 and, by the time of this FY14 announcement, it had received 93 applications with 26 recommended for funding, reflecting a competitive, selective program focused on novelty and impact.

The core purpose of the award is hypothesis-driven exploration. Applicants are expected to propose a well-formulated, testable hypothesis supported by strong scientific rationale and a solid study design. Preliminary data and prior publications can be included and may strengthen the rationale, but they are not required, which signals that the program is willing to consider genuinely new concepts that may not yet have an extensive evidence base. At the same time, the proposal cannot be vague or purely speculative; it still needs a clear hypothesis and a credible plan to test it.

A major emphasis of the EHDA is innovation. The program is looking for research that introduces a new paradigm, challenges prevailing assumptions, reframes known problems from a different angle, or otherwise demonstrates substantial creativity. The announcement is explicit that incremental extensions of existing published work are not considered innovative and do not align with the intent of this mechanism. Because of that, the Principal Investigator is responsible for directly explaining, in plain terms, what makes the approach groundbreaking within TSC research and why it is more than a routine next step.

Human subjects research is allowed, but only under limited regulatory pathways. Studies involving human participants or human anatomical substances must qualify as exempt under 32 CFR 219.101(b) or be eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110. The applicant’s Institutional Review Board (IRB) makes the initial determination of whether the study is exempt or qualifies for expedited review, and investigators must follow their institution’s IRB submission requirements accordingly. Any project that does not meet exempt or expedited criteria will be administratively withdrawn, meaning it will not proceed through review or funding consideration. Importantly, clinical trials are not permitted under this opportunity; investigators interested in pilot clinical trials are directed instead to a separate TSCRP Pilot Clinical Trial Award mechanism listed in the notice.

Administratively, this FY14 funding opportunity is listed as Funding Opportunity Number W81XWH 14 TSCRP EHDA, categorized as discretionary funding, and offered through grants and cooperative agreements under the Science and Technology and other Research and Development activity category. The program anticipated making about 7 awards with an estimated total funding pool of $1,120,000, and it did not require cost sharing or matching funds. Eligibility was described as unrestricted, meaning it was generally open to a wide range of applicant organization types, subject to any additional eligibility clarifications contained in the full announcement. The opportunity was posted May 27, 2014, with a closing date of July 24, 2014, and it was associated with CFDA number 12.420 (Military Medical Research and Development).

For applicants needing help accessing or navigating the announcement and submission systems, the notice points to the CDMRP help resources available through eBRAP (the electronic Biomedical Research Application Portal) and provides the help desk contact information (help@eBRAP.org, 301-682-5507).

FAQs: DoD TSCRP Exploration Hypothesis Development Award (EHDA) - FY14

What is the TSCRP Exploration Hypothesis Development Award (EHDA)?

The Exploration Hypothesis Development Award (EHDA) is a funding mechanism under the DoD Tuberous Sclerosis Complex Research Program (TSCRP) intended to kick-start bold, early-stage ideas in tuberous sclerosis complex (TSC) research. It is designed for high-risk, potentially high-reward projects that can open new directions in the field and lay the groundwork for future, larger studies.

Who administers this funding opportunity?

This opportunity is offered through the U.S. Army Medical Research Acquisition Activity (USAMRAA).

What is the main purpose of the EHDA mechanism?

The core purpose is hypothesis-driven exploration. Applicants are expected to propose a well-formulated, testable hypothesis backed by strong scientific rationale and a solid study design, with the aim of generating a foundation for future, more extensive research.

Is preliminary data required to apply?

No. Preliminary data and prior publications may be included and may strengthen the rationale, but they are not required. The mechanism is intended to allow genuinely new concepts that may not yet have a large evidence base.

If preliminary data is not required, can proposals be speculative?

No. Even though preliminary data is not required, proposals cannot be vague or purely speculative. They must include a clear, testable hypothesis and a credible plan to test it.

What kind of research is considered a strong fit for this award?

The EHDA specifically targets research that is high risk but potentially high reward, with an emphasis on projects expected to open new directions in TSC research and provide a foundation for future work.

How important is innovation in this opportunity?

Innovation is a major emphasis. The program seeks work that introduces a new paradigm, challenges prevailing assumptions, reframes known problems from a different angle, or otherwise demonstrates substantial creativity in TSC research.

Are incremental studies or routine extensions of prior work considered innovative under this mechanism?

No. The announcement explicitly states that incremental extensions of existing published work are not considered innovative and do not align with the intent of this mechanism.

What is the Principal Investigator expected to explain regarding innovation?

The Principal Investigator is responsible for clearly explaining what makes the approach groundbreaking within TSC research and why it is more than a routine next step.

Is human subjects research allowed under the EHDA?

Yes, but only under limited regulatory pathways. Studies involving human participants or human anatomical substances must qualify as exempt under 32 CFR 219.101(b) or be eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110.

Who determines whether a human subjects study is exempt or eligible for expedited review?

The applicant's Institutional Review Board (IRB) makes the initial determination of whether the study is exempt or qualifies for expedited review, and investigators must follow their institution's IRB submission requirements.

What happens if a proposed human subjects study does not qualify as exempt or expedited?

Any project that does not meet exempt or expedited criteria will be administratively withdrawn, meaning it will not proceed through review or funding consideration.

Are clinical trials permitted under this funding opportunity?

No. Clinical trials are not permitted under this opportunity. Investigators interested in pilot clinical trials are directed to a separate TSCRP Pilot Clinical Trial Award mechanism referenced in the notice.

What is the Funding Opportunity Number for this announcement?

The Funding Opportunity Number is W81XWH 14 TSCRP EHDA.

What type of funding is this categorized as?

The notice describes it as discretionary funding and indicates it is offered through grants and cooperative agreements under the Science and Technology and other Research and Development activity category.

How many awards were anticipated and what was the estimated total funding pool?

The program anticipated making about 7 awards, with an estimated total funding pool of $1,120,000.

Is cost sharing or matching funding required?

No. The opportunity did not require cost sharing or matching funds.

Who is eligible to apply?

Eligibility was described as unrestricted, meaning it was generally open to a wide range of applicant organization types, subject to any additional eligibility clarifications contained in the full announcement.

When was this opportunity posted and when did it close?

The opportunity was posted on May 27, 2014, and had a closing date of July 24, 2014.

What is the CFDA number associated with this opportunity?

The opportunity was associated with CFDA number 12.420 (Military Medical Research and Development).

How competitive is the EHDA mechanism?

The mechanism has been offered since FY07. By the time of the FY14 announcement, it had received 93 applications with 26 recommended for funding, reflecting a competitive and selective program focused on novelty and impact.

Where can applicants get help with the announcement or submission systems?

The notice points to CDMRP help resources available through eBRAP (the electronic Biomedical Research Application Portal). It also provides the eBRAP help desk contact information: help@eBRAP.org and 301-682-5507.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD Tuberous Sclerosis Complex Idea Development Award

Previous opportunity: Implement PPJV Conservation Activities in Montana

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 14 TSCRP EHDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 14 TSCRP EHDA) also looked into and applied for these:

Funding Opportunity
DoD Tuberous Sclerosis Complex Idea Development Award Apply for W81XWH 14 TSCRP IDA

Funding Number: W81XWH 14 TSCRP IDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Tuberous Sclerosis Complex Pilot Clinical Trial Award Apply for W81XWH 14 TSCRP PCTA

Funding Number: W81XWH 14 TSCRP PCTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Neurofibromatosis Investigator Initiated Research Award Apply for W81XWH 14 NFRP IIRA

Funding Number: W81XWH 14 NFRP IIRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Neurofibromatosis New Investigator Award Apply for W81XWH 14 NFRP NIA

Funding Number: W81XWH 14 NFRP NIA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Neurofibromatosis Clinial Trial Award Apply for W81XWH 14 NFRP CTA

Funding Number: W81XWH 14 NFRP CTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Neurofibromatosis Exploration Hypothesis Development Award Apply for W81XWH 14 NFRP EHDA

Funding Number: W81XWH 14 NFRP EHDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Central Valley Project Conservation Program and Central Valley Project Improvement Act Habitat Restoration Program Apply for R14AS00050

Funding Number: R14AS00050
Agency: Bureau of Reclamation
Category: Science and Technology and other Research and Development
Funding Amount: $1,000,000
CENTER OF EXCELLENCE Electromagnetic Interference for Extreme Electromagnetic Environments Apply for BAA AFOSR 2014 0002

Funding Number: BAA AFOSR 2014 0002
Agency: Air Force Office of Scientific Research
Category: Science and Technology and other Research and Development
Funding Amount: $6,000,000
DoD Prostate Cancer Exploration Hypothesis Development Award Apply for W81XWH 14 PCRP EHDA

Funding Number: W81XWH 14 PCRP EHDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Laboratory Clinical Transition Award Apply for W81XWH 14 PCRP LCTA

Funding Number: W81XWH 14 PCRP LCTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Postdoctoral Training Award Apply for W81XWH 14 PCRP PTA

Funding Number: W81XWH 14 PCRP PTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Physician Research Training Award Apply for W81XWH 14 PCRP PRTA

Funding Number: W81XWH 14 PCRP PRTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Dr. Barbara Terry Koroma Health Disparity Research Award Apply for W81XWH 14 PCRP HDRA

Funding Number: W81XWH 14 PCRP HDRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Collaborative Undergraduate Historically Black Colleges and Universities Student Summer Training Program Award Apply for W81XWH 14 PCRP STPA

Funding Number: W81XWH 14 PCRP STPA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Population Science Impact Award Apply for W81XWH 14 PCRP PSIA

Funding Number: W81XWH 14 PCRP PSIA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Early Stage Innovations (ESI) Apply for NNH14ZOA001N 14ESI B2

Funding Number: NNH14ZOA001N 14ESI B2
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $500,000
Tribal Colleges and Universities Program Apply for 14 572

Funding Number: 14 572
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $2,500,000
ADVANCE Increasing the Participation and Advancement of Women in Academic Science and Engineering Careers Apply for 14 573

Funding Number: 14 573
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $4,000,000
Cooperative Ecosystem Studies Unit, Great Basin Apply for G14AS00076

Funding Number: G14AS00076
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Spinal Cord Injury Investigator Initiated Research Award Apply for W81XWH 14 SCIRP IIRA

Funding Number: W81XWH 14 SCIRP IIRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 14 TSCRP EHDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.